Urologic Imaging

Should You Order MRU or CTU for an Initial Gross Hematuria Workup?

·
Should You Order MRU or CTU for an Initial Gross Hematuria Workup?

A 62-year-old male with a 30-pack-year smoking history presents to your clinic after noticing blood in his urine this morning. He describes it as painless and consistent throughout the stream. His physical exam is unremarkable, and basic labs are pending. You know that painless gross hematuria in an older adult with smoking history is a significant warning sign for malignancy, and your next step is to choose the right initial imaging study to evaluate the entire urinary tract. This article details the clinical workflow for this exact scenario, explaining why the American College of Radiology (ACR) rates MR Urography (MRU) without and with IV contrast as Usually Appropriate for the initial imaging of gross hematuria.

Who Fits This Clinical Scenario?

This guidance applies to adult patients presenting with gross hematuria for the first time, where the cause is not immediately obvious. Gross hematuria is defined as blood in the urine that is visible to the naked eye. The key elements of this scenario are:

  • Visible Blood: The patient reports seeing red, pink, or “cola-colored” urine.
  • Initial Workup: This is the first imaging study being ordered for this specific presentation. It does not apply to surveillance imaging for known conditions or follow-up of a previously identified abnormality.
  • Non-Traumatic: The hematuria is not the result of a recent injury, which would trigger a different diagnostic pathway (e.g., trauma CT).

This workflow is distinct from other related presentations. It is crucial not to apply this guidance to patients who fit into different ACR variants, such as:

  • Microscopic Hematuria: This is defined by laboratory analysis (e.g., >3 red blood cells per high-power field) and is not visible to the patient. The workup for microhematuria depends heavily on the presence or absence of risk factors for malignancy.
  • Hematuria with Suspected Infection: If the patient has clear signs of a urinary tract infection (e.g., fever, dysuria, pyuria), imaging may be deferred until after treatment to see if the hematuria resolves.
  • Pregnant Patients: Imaging choices are significantly altered in pregnancy to avoid radiation and contrast agents where possible, prioritizing ultrasound.

What Diagnoses Are You Working Up in This Scenario?

Gross hematuria is a sign that demands a thorough evaluation of the entire urinary tract, from the kidneys to the urethral meatus. The primary goal of imaging is to identify or exclude serious pathology, particularly malignancy.

Urothelial Carcinoma: This is the most consequential diagnosis to exclude. Urothelial carcinoma can arise anywhere along the lining of the collecting system, including the renal pelvis, ureters, and bladder. Painless gross hematuria is the classic presenting symptom, and risk factors like advanced age and smoking history significantly increase suspicion. Imaging must be capable of detecting small filling defects or mucosal thickening within these structures.

Renal Cell Carcinoma (RCC): While the classic triad of flank pain, palpable mass, and hematuria is rare, hematuria is a common presenting sign of kidney cancer. Imaging must be able to detect and characterize solid renal masses, distinguishing them from benign cysts or other entities.

Urolithiasis (Kidney Stones): Stones are a frequent cause of hematuria, which can be gross or microscopic. While often associated with severe flank pain, stones can sometimes present with painless bleeding. Imaging helps identify the size, location, and any associated obstruction (hydronephrosis).

Benign and Medical Causes: Less common but important considerations include benign prostatic hyperplasia (BPH), which can cause bleeding from engorged vessels; complex renal cysts; arteriovenous malformations (AVMs); and medical renal diseases like IgA nephropathy or glomerulonephritis. While imaging may not diagnose medical renal disease directly, it is crucial for ruling out the structural and malignant causes first.

Why Is MRU Without and With IV Contrast a Recommended Study?

For the initial workup of gross hematuria, the ACR designates both MR Urography (MRU) without and with IV contrast and CT Urography (CTU) without and with IV contrast as Usually Appropriate. While CTU is also an excellent choice, MRU offers a key advantage: the absence of ionizing radiation.

An MRU is a specialized MRI protocol designed to provide a comprehensive evaluation of the entire urinary tract. It combines standard anatomical imaging of the kidneys and bladder with functional, excretory-phase imaging to visualize the ureters. The rationale for its high rating includes:

  • Superior Soft Tissue Contrast: MRU provides exceptional detail for characterizing renal masses, distinguishing solid tumors from complex cysts, and identifying subtle urothelial thickening or masses within the collecting system and bladder.
  • No Ionizing Radiation: With a radiation level of O (0 mSv), MRU is an ideal choice for younger patients, those who may require future surveillance imaging, or any patient wishing to avoid radiation exposure. This stands in stark contrast to CTU, which carries a high radiation dose (☢☢☢☢ 10-30 mSv).
  • Comprehensive Evaluation: A complete MRU protocol includes non-contrast sequences, dynamic contrast-enhanced phases to evaluate renal parenchymal enhancement, and delayed excretory phases where urine containing gadolinium fills and distends the collecting system, allowing for detailed assessment of the ureters and bladder.

How do alternative studies compare for this specific scenario?

  • CT Urography (CTU) without and with IV contrast: Also rated Usually Appropriate, CTU is often faster and more widely available than MRU. It is superior for detecting calcified stones. However, its significant radiation dose makes MRU a more favorable option when available and not contraindicated.
  • US kidneys and bladder retroperitoneal: Rated May be appropriate. Ultrasound is excellent for detecting hydronephrosis and larger renal masses, and it involves no radiation. However, it is highly operator-dependent and has poor sensitivity for small renal masses, nearly all ureteral pathology, and many bladder tumors. It is not considered a definitive study for a high-risk presentation like gross hematuria.
  • CT abdomen and pelvis without and with IV contrast: Rated May be appropriate. A standard contrast-enhanced CT is not the same as a CTU. It lacks the crucial non-contrast and delayed excretory phases needed to detect stones and visualize the urothelium, respectively. Ordering a standard CT can miss key diagnoses and is an incomplete study for this indication.

What’s Next After MRU? Downstream Workflow

The results of the MRU guide the subsequent clinical pathway, but it’s critical to remember that imaging is only one part of the complete workup for gross hematuria.

  • If the MRU is positive for a suspicious mass (renal or urothelial): The next step is an urgent referral to a urologist. This will typically lead to cystoscopy for direct visualization and biopsy of any bladder or urethral lesions, and potentially ureteroscopy or percutaneous biopsy for upper tract lesions. The imaging findings are critical for surgical planning.
  • If the MRU is positive for urolithiasis: The patient should be managed for kidney stones, which may involve a urology consultation for observation, medical expulsive therapy, or procedural intervention depending on the stone’s size, location, and associated symptoms or obstruction.
  • If the MRU is negative: This is a crucial decision point. A negative upper tract imaging study (MRU or CTU) does not complete the workup for gross hematuria. The risk of a bladder malignancy remains significant, and these can be missed on cross-sectional imaging. The standard of care is to proceed with cystoscopy to directly inspect the bladder mucosa. Urine cytology may also be sent. If both imaging and cystoscopy are negative, the workup may be concluded, or a nephrology consult may be considered to evaluate for medical renal disease.
  • If the MRU is indeterminate: An indeterminate finding, such as a complex renal cyst, may require follow-up imaging or characterization with an alternative modality (e.g., a contrast-enhanced ultrasound or CT) to arrive at a definitive diagnosis.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for gross hematuria requires avoiding several common missteps that can delay diagnosis or lead to incomplete evaluations.

  • Ordering the Wrong Protocol: Requesting a “CT Abdomen/Pelvis with contrast” instead of a dedicated “CT Urogram” will miss the non-contrast and excretory phases, potentially overlooking stones and urothelial tumors. Be specific in your order.
  • Stopping After Negative Imaging: The most significant pitfall is assuming a negative MRU or CTU rules out cancer. Gross hematuria mandates a urology referral for cystoscopy, regardless of imaging results.
  • Ignoring Contrast Contraindications: Always check renal function (eGFR) before ordering a contrast-enhanced study. For patients with severe renal impairment, a non-contrast protocol or alternative study may be necessary.
  • Attributing Hematuria to Anticoagulation: While anticoagulants can potentiate bleeding, they do not cause it. Hematuria in an anticoagulated patient should be worked up with the same urgency, as it may be unmasking an underlying pathology.

If you identify a suspicious mass or if the source of bleeding remains unclear after initial imaging, escalation to a urologist is always the appropriate next step.

Related ACR Topics and Tools

This article focuses on a single, common clinical scenario. For a comprehensive overview of imaging for all hematuria variants, from microscopic to post-procedural, please consult our parent guide. For help with ordering, protocoling, and discussing radiation dose, the following GigHz tools can streamline your workflow.

Frequently Asked Questions

Why is MRU preferred over CTU when both are ‘Usually Appropriate’ for gross hematuria?

Both are excellent studies. However, MR Urography (MRU) does not use ionizing radiation (0 mSv), making it a safer choice, particularly for younger patients or those who might need multiple scans over time. CT Urography (CTU) is faster and better for detecting small calcified stones but involves a significant radiation dose (10-30 mSv). The choice often depends on patient factors, institutional availability, and the specific clinical question.

My patient has renal insufficiency. Can I still order a contrast-enhanced MRU or CTU?

This requires careful consideration. For CTU, iodinated contrast carries a risk of contrast-induced nephropathy. For MRU, gadolinium-based contrast agents carry a risk of nephrogenic systemic fibrosis (NSF) in patients with severe renal dysfunction (typically eGFR < 30 mL/min/1.73m²). In such cases, a non-contrast study (non-contrast CT or MRI) or an ultrasound may be performed first. A discussion with the radiologist and a nephrologist is recommended to weigh the risks and benefits.

If the MRU is negative, is the workup for gross hematuria complete?

No. This is a critical point. A negative MRU or CTU provides strong evidence against upper tract (kidney or ureter) pathology, but it is not sensitive enough to definitively rule out bladder cancer. The standard of care for gross hematuria includes direct visualization of the bladder with cystoscopy, which should be performed by a urologist even if imaging is negative.

Is ultrasound a reasonable first step for gross hematuria?

Ultrasound is rated ‘May be appropriate’ by the ACR. It is a good, non-invasive tool for assessing the kidneys for hydronephrosis or large masses and checking the bladder for large tumors or post-void residual. However, it cannot visualize the ureters well and has low sensitivity for small tumors in the kidneys or bladder. For a high-risk presentation like painless gross hematuria, a more definitive study like MRU or CTU is typically required to evaluate the entire urinary tract.

What is the difference between a standard MRI of the abdomen and an MR Urogram?

A standard MRI of the abdomen is designed to evaluate solid organs like the liver, spleen, and pancreas. An MR Urogram (MRU) is a specialized protocol optimized for the urinary system. It includes specific high-resolution sequences of the kidneys and bladder, as well as a delayed excretory phase after contrast administration. In this phase, the gadolinium-containing urine fills the collecting system, ureters, and bladder, allowing for detailed evaluation of their lining for abnormalities like urothelial carcinoma.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026